Annals of Chinese Medicine https://heyttu.com/journals-submission/index.php/acm <p><em>Annals of Chinese Medicine</em> (ACM) is an interdisciplinary multi-lingual journal focusing on clinical studies and basic researches in the field of Chinese Medicine. It aims to be a leading journal to present research advances and achievements in this field and to promote the blending among acupuncture, herbal medicine, complementary and alternative medicine (CAM), and bio-medicine. Annals of Chinese Medicine covers all aspects of Chinese Medicine, including acupuncture, moxibustion, herbal medicine and other forms of CAM approaches, e.g. mind-body medicine, diet, Taichi, Qigong, meditation, as well as their integration with the conventional medicine.</p> <p>&nbsp;</p> en-US <p><!-- wp:paragraph --></p> <p>Heyttu journals apply the Hybrid method with open access (Gold) and traditional publishing method. Authors need to choose either with Open Access or Traditional Publishing.</p> <p><!-- /wp:paragraph --> <!-- wp:heading --></p> <h2>1. Open Access</h2> <p><!-- /wp:heading --> <!-- wp:image {"id":1183,"align":"left","width":186,"height":74} --></p> <div class="wp-block-image"> <figure class="alignleft is-resized"><img class="wp-image-1183" src="https://heyttu.com/wp-content/uploads/2019/04/Open_Access_PLoS.svg_-1-1024x410.png" alt="" width="186" height="74"></figure> </div> <p><!-- /wp:image --> <!-- wp:paragraph --></p> <p>Open access (OA) refers to free, unrestricted online access to research outputs such as journal articles and books. OA content is open to all, with no access fees. OA content can reach more reader and faster popularization.</p> <p><!-- /wp:paragraph --> <!-- wp:paragraph --></p> <p>Most of journals published with Heyttu follow the guidelines of <a href="https://preview.springernature.com/gp/open-research/about/what-is-open-access">Gold Open Access</a>. The OA articles on Heyttu journals apply the Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0). Read more about the policy in <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/">English</a>/<a href="https://creativecommons.org/licenses/by-nc-nd/4.0/deed.zh">中文</a>/<a href="https://creativecommons.org/licenses/by-nc-nd/4.0/deed.da">Dansk</a>/<a href="https://creativecommons.org/licenses/by-nc-nd/4.0/deed.de">Deutsch</a>. <br>If a author select the mode of OA publication, the author holds the copyright and agree to make the submission open to all and needs to pay a article processing change (APC) of 300 EURO.</p> <p><!-- /wp:paragraph --> <!-- wp:heading --></p> <h2>2. Traditional Publishing</h2> <p><!-- /wp:heading --> <!-- wp:paragraph --></p> <p>The papers are published and possibly printed with a set number of issues each year. Readers, both individuals and institutions, can subscribe to the journal for an annual fee. Single issues or articles can usually be purchased. There is no APC fee if an author choose to publish with the traditional mode. But the author needs to transfer the copyright of his/her paper to Heyttu journals.</p> <p><strong><span style="text-decoration: underline;">COPYRIGHT TRANSFER AGREEMENT</span></strong></p> <p>If the author(s) select to publish a manuscript with the traditional method (not Open Access), the copyright transfer agreement should be made.</p> <p>Application for copyright transfer will be made check "Require authors to agree to the Copyright Notice as part of the submission process." and attestation to the following:</p> <p>1.That the manuscript is not simultaneously being considered by other journals or is already published elsewhere.<br>2.That the manuscript has no redundancy, plagiarism, data fabrication, or falsification.<br>3.That the author(s) has (have) no conflict of interest related to the manuscript.<br>4.That all experiments involving animals and human subjects were designed and performed in compliance with the relevant laws regarding the humane care and use of subjects.<br>5.That the material contained within the manuscript is original, with all information from other sources appropriately referenced, and that written specific permission has been granted by any existing copyright holders prior to publication and is clearly cited and available.<br>6.That the author(s) agree to transfer to Heyttu Academic Publishing exclusive copyright ownership for all formats of the manuscript, including print and electronic formats, English and non-English language formats, and subsequent editions such as Erratum, in addition to all rights for (1) granting permission to republish or reprint the materials in whole or in part, with or without a fee, (2) printing copies for free distribution or for sale, and (3) republishing the materials in a compendium or in any other format. <br>7.That there are no errors in grammar, syntax, spelling, punctuation, or logic.<br>8.That all figures and tables have been correctly placed and clearly identified, and meet the journal’s standards of high-resolution quality.<br>9.That the references are numbered according to their order of appearance in the main text of the manuscript.</p> <p><!-- /wp:paragraph --></p> acm@heyttu.com (Editor-in-Chief) acm@heyttu.com (Yahong Zheng) Tue, 10 Mar 2020 19:05:48 +0000 OJS 3.1.2.1 http://blogs.law.harvard.edu/tech/rss 60 Treatment for Multiple Sclerosis: Kidney-Du-Brain Axis (KIDUBA) Acupuncture Protocol https://heyttu.com/journals-submission/index.php/acm/article/view/2 <p>Multiple sclerosis (MS) is a complex autoimmune disease mediated by an immune response to central nervous system antigens. Conventional immunomodulatory therapies are limited to relieve many of the symptoms, such as weakness, pain and depression, but probably cause side effects. Acupuncture, the most popular approach of complementary and alternative medicine (CAM) could improve the quality of life (QoL), fatigue, and pain, and alleviate the side-events of immunosuppresants. The essay summarized the publications and experiences from the leading acupuncture masters in China and clinical trials on acupuncture treatment for MS patients. The review concluded that in Chinese Medicine (CM), the Kidney-DU-Brain Axis (KIDUBA) plays a key role in the pathogenesis of MS. Fundamental acupoints including GB39, SP6, DU4, BL23, SI3, Sishencong are recommended according to the principle of supplementing kidney and marrow and opening blockages in Du channel and the brain. Besides, acupuncture treatment for the side effects of immunomodulatory medications are covered in the protocol.</p> Han Lai, Yi Xiang Liu, Hui Zhang Copyright (c) https://heyttu.com/journals-submission/index.php/acm/article/view/2 Wed, 04 Sep 2019 00:00:00 +0000 Discussion on the clinical use of Shi Zao Tang (Ten Jujubes Decoction) https://heyttu.com/journals-submission/index.php/acm/article/view/CN000001 <p>Ascites is a common dangerous and lethal complication of the liver cirrhosis. In Chinese Medicine, the ascites due to the liver cirrhosis belongs to Gu Zhang i.e. drum distention, which can be treated by Shi Zao Tang (Ten Jujubes Decoction). Although the Shi Zao Tang with Wan Yua (<em>Flos Genkwa</em>), Gan Sui (Radix Kansui), and Da Ji (<em>Radix Euphorbiae Pekinensis</em>) drastically purging and expel water, the herbs are toxic, which must be restrained by the proper use of Da Zao (<em>Fructus Jujube</em>). Additionally, Gu Zhang is characterized by deficient Ben-root and excess Biao-branch. Therefore, clinical attention should be given to carefully neutralize the toxicity of the three herbs, based on the correct diagnosis of the Ben-root and Biao -branch.</p> <p><strong>【摘 </strong><strong>要】</strong>腹水是肝硬化最常见的并发症之一,严重威胁患者的健康和生命。肝硬化腹水属于中医“臌胀”的范畴,可运用十枣汤峻下逐水。但需要注意的是芫花、甘遂、大戟药性峻猛有毒,需合理配伍大枣减轻毒性。此外臌胀属于本虚标实之症,临证需要注意:稳中求效、避免攻邪伤正,用药谨守法度、把握“衰其大半而止”的原则,尊古不泥古、灵活变通、中西医结合,辨证求因、谨守病机、治病求本。</p> Jun Yu He Copyright (c) 2020 Annals of Chinese Medicine https://heyttu.com/acm/publishing-policy/ https://heyttu.com/journals-submission/index.php/acm/article/view/CN000001 Mon, 09 Mar 2020 00:00:00 +0000 Acupuncture Treatment for 23 Types of Pain, 2018 (ATP-2018) https://heyttu.com/journals-submission/index.php/acm/article/view/5 <p>The review is aimed to retrospectively evaluate the use of acupuncture to treat pain from the publications in 2018. All publications on this subject were screened from the MEDLINE database of Pubmed, and only clinical reports including randomized control trails and case reports were involved. In 2018, there were 35 publications from 14 academic journals which reported clinical research/trails on the treatment of pain by acupuncture alone or in combination wither other modalities, e.g. moxibustion, electricity, and tuina. Among the 23 types of pain, pain resulting from knee osteoarthritis (5/23) was mostly concerned. Other categories covered dysmenorrhea (3/23), lower back pain (3/23), neck pain (2/23), fibromyalgia (2/23), chemotherapy neuropathy (2/23) and so on (Table 1). Interestingly, knee osteoarthritis patients accounted for 21.16% of the 2760 participants. The main findings, acupoints and procedures were presented in this review as the Chinese Medicine Publication Index (CMPI) for pain treatment with acupuncture. According to the CMPI, a conclusion that acupuncture could be beneficial to treat 23 types of pain can be made.</p> Hui Zhang Copyright (c) 2020 Annals of Chinese Medicine https://heyttu.com/acm/publishing-policy/ https://heyttu.com/journals-submission/index.php/acm/article/view/5 Tue, 10 Mar 2020 00:00:00 +0000